Results 1 to 10 of about 11,900 (212)

Depo Medroxyprogesterone Acetate (DMPA): Long-Term Effects on Menstrual Cycle Disorders [PDF]

Indonesian Journal of Obstetrics and Gynecology, 2023
bjective: To determine the effect of the duration of using Depo Medroxyprogesterone Acetate (DMPA) on the Menstrual Cycle. Methods: This research is an analytical study of 102 patients who used DMPA for less than 1 year and more than 1 year and then ...
Nurhayati Nurhayati, Suhermi S, Sitti H. Hamang   +2 more
doaj   +3 more sources

From Awareness to Autonomy: Exploring the Knowledge Gap and Acceptability of Self-Injectable DMPA-SC among Women in Central India [PDF]

Indian Journal of Community Medicine
Background: Self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) provides a novel contraceptive modality that can expand access, autonomy, and continuation rates, especially among low-resource populations.
Anita Yadav, Anusha Kamath, Jyoti Baghel, Neha Gangane, Amruta Choudhary, Shuchita Mundle   +5 more
doaj   +2 more sources

A Comparative Evaluation of Cut 380A Intrauterine Device Versus Depot Medroxyprogesterone Acetate For Long-Acting Reversible Contraception [PDF]

Journal of Pharmacy and Bioallied Sciences
Background: India’s family-planning program increasingly emphasizes long-acting reversible contraceptives (LARCs) to curb unintended pregnancy. Copper T 380A (CuT 380A) intrauterine device (IUCD) and injectable depot medroxyprogesterone acetate (DMPA ...
Manisha Meena, Rupali Dewan
doaj   +2 more sources

Feasibility and acceptability of DMPA-SC self-injection in Addis Ababa, Ethiopia: a mixed-methods study [PDF]

Reproductive Health
Background Depot Medroxyprogesterone Acetate (DMPA) in a prefilled auto-disabled subcutaneous injectable contraceptive (Uniject™) can be administered by community health workers and clients.
Aderaw Anteneh, Megan M. Lydon, Katherine M. Anfinson, Fikreselassie Getachew, Erica Felker-Kantor, Tihut Mulugeta, Teferi Teklu, Rahel Demissew, Holly M. Burke   +8 more
doaj   +2 more sources

Weight changes 12-18 months after IUD and DMPA usage: A retrospective cohort study [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2020
Introduction: Intra Uterine Device (IUD) and Depo-medroxy Progesterone Acetate (DMPA) are effective contraceptive methods that their usage may not be continued due to the occurrence of side effects.
Fatemeh Alavi-Arjas, Farnaz Farnam
doaj   +1 more source

Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients

National Journal of Physiology, Pharmacy and Pharmacology, 2023
Background: Contraception is the intentional use of artificial methods or other techniques to prevent pregnancy as a consequence of sexual intercourse. Progesterone only injectables are highly effective in preventing in pregnancy as they do not rely on ...
Jayun M Joshi, Harsh M Joshi, Hetal Patel, Param S Patel   +3 more
doaj   +1 more source

Comparison of Depot Medroxyprogesterone Acetate and Postpartum Intrauterine Contraceptive Device in a Teaching Institute of Rural Bengal: A Longitudinal Cohort Study [PDF]

Journal of Clinical and Diagnostic Research, 2021
Introduction: Contraception is one of the proximate determinants of fertility and the most important predictor of fertility transition. Depot Medroxy Progesterone Acetate (DMPA) and Intrauterine contraceptive device share some common features- both ...
Sougata Kumar Burman, Jayeeta Mukherjee, Ranita Roy Chowdhury, Soumen Deb   +3 more
doaj   +1 more source

Differential Elevation of Inflammation and CD4+ T Cell Activation in Kenyan Female Sex Workers and Non-Sex Workers Using Depot-Medroxyprogesterone Acetate

Frontiers in Immunology, 2021
BackgroundDepot Medroxyprogesterone (DMPA) is one of the most widely used contraceptives in Sub-Saharan Africa where HIV incidence is high. We explored the effect of DMPA on the activation of HIV cellular targets and inflammation as a possible mechanism ...
Kenneth Omollo, Kenneth Omollo, Julie Lajoie, Julie Lajoie, Julius Oyugi, Julius Oyugi, Jocelyn M. Wessels, Dufton Mwaengo, Joshua Kimani, Joshua Kimani, Charu Kaushic, Charu Kaushic, Keith R. Fowke, Keith R. Fowke, Keith R. Fowke, Keith R. Fowke   +15 more
doaj   +1 more source

Multi-omics analysis of the cervical epithelial integrity of women using depot medroxyprogesterone acetate.

PLoS Pathogens, 2022
Depot medroxyprogesterone acetate (DMPA) is an injectable hormonal contraceptive used by millions of women worldwide. However, experimental studies have associated DMPA use with genital epithelial barrier disruption and mucosal influx of human ...
Frideborg Bradley, Mathias Franzén Boger, Vilde Kaldhusdal, Alexandra Åhlberg, Gabriella Edfeldt, Julie Lajoie, Sofia Bergström, Kenneth Omollo, Anastasios Damdimopoulos, Paulo Czarnewski, Anna Månberg, Julius Oyugi, Joshua Kimani, Peter Nilsson, Keith Fowke, Annelie Tjernlund, Kristina Broliden   +16 more
doaj   +1 more source

Sexual Function in Women Using DMPA Injection and Copper Intrauterine Device [PDF]

Thai Journal of Obstetrics and Gynaecology, 2016
Objectives: To study the sexual function and the prevalence of sexual dysfunction in women using depot medroxyprogesterone acetate (DMPA) and copper intrauterine device (copper IUD) contraceptives.Materials and Methods: A cross-sectional ...
Yada Saptatangtrakul, Rujira Wattanayingcharoenchai, Jittima Manonai, Komkrit Aimjirakul   +3 more
doaj   +1 more source